India's IP snub.
作者信息
Jayaraman K S
出版信息
Nat Biotechnol. 2008 Apr;26(4):362. doi: 10.1038/nbt0408-362b.
PMID:18392000
Abstract
摘要
相似文献
1
India's IP snub.
Nat Biotechnol. 2008 Apr;26(4):362. doi: 10.1038/nbt0408-362b.
2
US courts narrow patent exemptions.
Nat Biotechnol. 2003 Aug;21(8):834. doi: 10.1038/nbt0803-834.
3
Four rebuffs for Cabilly.
Nat Biotechnol. 2008 Apr;26(4):362. doi: 10.1038/nbt0408-362a.
4
Proposed changes to patent code loom over biotech industry.
Nat Biotechnol. 2007 Dec;25(12):1333-4. doi: 10.1038/nbt1207-1333.
5
Australia experiments with 'experimental use' exemption.
Nat Biotechnol. 2004 Aug;22(8):1023-5. doi: 10.1038/nbt0804-1023.
6
The coming US patent opposition.
Nat Biotechnol. 2005 Feb;23(2):245-7. doi: 10.1038/nbt0205-245.
7
Protecting rights to early-stage technology.
Nat Biotechnol. 2003 Jun;21(6):701-3. doi: 10.1038/nbt0603-701.
8
A license to print money?
Nat Biotechnol. 2006 Jun;24(6):593. doi: 10.1038/nbt0606-593.
9
Equivalents in biotechnology patents.
Nat Biotechnol. 2003 Mar;21(3):329-31. doi: 10.1038/nbt0303-329.
10
Cabilly patent finale.
Nat Biotechnol. 2008 Aug;26(8):846. doi: 10.1038/nbt0808-846b.
Zotero 插件